Offering Premier members access to the Protenus award-winning solution to support hospital diversion prevention and compliance programs
Protenus has been awarded a national group purchasing agreement for Drug Diversion Software Solutions with Premier, Inc. Effective March 1, 2024, the new agreement allows Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier for the Protenus Drug Diversion Software Surveillance solution.
Nick Culbertson, CEO and Co-founder of Protenus, states, "Some of the largest health systems and academic medical centers across the U.S. depend on our solutions to preemptively detect inappropriate behavior linked to drug diversion. We're honored to be a Premier Contracted Supplier and are excited about collaborating with Premier members to support their objectives in the monitoring and eradicating risks of drug diversion within their organizations.” Read more >